Navigation Links
Amarin Provides 2010 Year-End Review to Shareholders
Date:1/31/2011

ata set at an appropriate scientific conference and securing various publications of the data
  • Announcement of the top-line data for the ANCHOR trial in the second quarter of 2011
  • Filing an NDA for AMR101 in 2011
  • Building a foundation for commercializing AMR101
  • Qualifying additional suppliers to establish greater supply diversification and capacity in preparation for AMR101 launch

  • We believe that the positive results from the MARINE trial support the significant potential for AMR101 in multiple relatively untapped markets.  Today, approximately 3.8 million patients in the U.S. alone are diagnosed with very high triglyceride levels over 500 mg/dL, an indication for which only one other omega-3 based drug is approved in the U.S. This prescription omega-3-based drug accounts for U.S. sales of approximately $1.0 billion.

    Additionally, approximately 36 million patients are currently diagnosed with high triglyceride levels between 200 and 500 mg/dL, a patient population for which there is no approved omega-3-based drug.  AMR101 is currently under investigation for this indication in the ongoing ANCHOR study.  Amarin will evaluate all options for seeking regulatory approval for, and commercializing, AMR101, with the goal of maximizing the global sales opportunity for AMR101 and, as a result, shareholder value.  

    ClosingI would like to thank our investors for their continued support as we move forward to seek regulatory approval for and commercialize AMR101. We will continue to make the Amarin management team available to our investors by participating in various investor conferences throughout the year. We have already begun this year with meetings and a presentation at the JPMorgan Healthcare Conference in San Francisco and are scheduled to present at a number of presentations in the first and second quarter of 2011. These include; Leerink Swann Hot Topics Conference (New York City, Febru
    '/>"/>

    SOURCE Amarin Corporation plc
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia
    2. Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
    3. Amarin to Present at UBS Life Sciences Conference
    4. Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010
    5. Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
    6. Amarin Prices Public Offering of American Depositary Shares
    7. Amarin Announces Underwriters Exercise of Over-Allotment Option
    8. Amarin Announces Successful Completion of Offering of American Depositary Shares
    9. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
    10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
    11. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2015)... July 30, 2015  Big Cloud Analytics, Inc. ... technology, announces it is working with Intel Corporation ... the new Lockheed Martin Healthcare Technology Alliance. The ... information technology providers, medical technology companies and academic ... innovation to improve care in rapidly evolving and ...
    (Date:7/30/2015)... , July 30, 2015  NanoSmart Pharmaceuticals, Inc., ... platforms, has received Orphan Drug Designation from the ... drug product that uses NanoSmart,s proprietary drug delivery ... dactinomycin for the treatment of Ewing,s sarcoma, a ... granted NanoSmart,s Orphan Drug Designation on the basis ...
    (Date:7/30/2015)... /PRNewswire/ - Anything Technologies Media, Inc. (OTC:EXMT) has announced ... Solutions (FIGS), www.frontiergarden.com has been announced ... Manager for a My Compassion originated medical cannabis ... in Alaska.  The project will be funded through ... Partners. The first phase of the project, is ...
    Breaking Medicine Technology:Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 2Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 3NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2Frontier Indoor Garden Solutions announced as Horticultural Supplier and Project Manager for Alaskan Tribal Medical Marijuana Grow Facility 2Frontier Indoor Garden Solutions announced as Horticultural Supplier and Project Manager for Alaskan Tribal Medical Marijuana Grow Facility 3
    ... Passage of Health Care Reform Bill , Critical ... , BOISE, Idaho, Nov. 7 Today the ... legislation that would strengthen Medicare for seniors and end discrimination ... affordable health coverage. , The Affordable Health Care ...
    ... patients with hereditary angioedema (HAE) have prodromal symptoms that ... time to initiate treatment and decrease the morbidity associated ... at the 2009 American College of Allergy, Asthma & ... as fatigue and nausea, which occur frequently before an ...
    Cached Medicine Technology:AARP Idaho Key Vote News Alert 2AARP Idaho Key Vote News Alert 3Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3
    (Date:7/30/2015)... Mequon, Wisconsin (PRWEB) , ... July 30, 2015 , ... ... rejuvenation. Kybella is a nonsurgical treatment designed specifically for the elimination ... is one of the first locations in the state of Wisconsin to offer this ...
    (Date:7/30/2015)... ... July 30, 2015 , ... ... Earns National Cancer Institute Designation , The Tisch Cancer Institute (TCI) at the ... Institute (NCI)-designated cancer center. TCI joins an elite group of 69 cancer institutions ...
    (Date:7/30/2015)... ... 2015 , ... Author Dr. Raul Llanos seeks to empower readers ... self-help book, “ Consciously Healing our Webs of Health, Wellbeing, Success, and Abundance ” ... take responsibility for ourselves, we can create better realities.” His book illustrates the possibilities ...
    (Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... fight with its Medicare administrative contractor (MAC) over submitted claims for bariatric surgery ... it a challenge to program integrity, Becky Dennis, a nurse auditor at WellSpan ...
    (Date:7/30/2015)... UT (PRWEB) , ... July 30, 2015 , ... When trying to gain weight, many people place a lot of ... amount of calories that need to be consumed. However, another key component to successful weight ... gain weight. To assist with this, CB-1 Weight Gainer gives three tips on when ...
    Breaking Medicine News(10 mins):Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 2Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 3Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 2Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 3
    ... features of the anthroposophical lifestyle, such as restrictive use ... allergic disease in children// , according to a new ... Steiner developed the anthroposophic lifestyle in which health is ... followers integrate modern medicine with alternative, nature-based treatments. ...
    ... to be reclassified again, according to campaigners. The UK’s Advisory ... drug //is connected to mental disorders. This may result in ... years. It had been classified as a Class C substance ... the use of the drug has to be conducted, as ...
    ... Erdogan tried to quell fears of a pandemic by saying ... country // , is now under control. ... monitor it closely," Erdogan newsmen with visiting Japanese Prime Minister ... out of the question," he added. People identified as carriers ...
    ... Indians (NRI) have been called upon by Oscar Fernandes, ... to take an active part in the AIDS awareness ... the involvement of related agencies and organizations to contribute ... announcement while addressing the Panel Discussion on HIV/AIDS in ...
    ... winter flu in the UK is reported to be on the decline. ... every 100,000 people. This figure // has been on the decline ... reason for this is reported to be the immunity that the people ... the mutations it goes through every year. ,Most of ...
    ... Scientists at the University of Bonn in Germany have come up ... that a substance present in sunflowers prevents // the AIDS virus ... this would also apply to the actual disease. ,The ... a new class of AIDS drugs. But this is available in ...
    Cached Medicine News:Health News:Anthroposophical Lifestyle Reduces Risk Of Allergic Disease In Children 2Health News:Turkish PM says bird flu under control 2Health News:Sunflowers Could Hold the Key to New Class of AIDS Drugs 2
    ... The Calypte AwareTM HIV-1/2 OMT test is ... vitro immunoassay for the,detection of antibodies to ... Type 2 (HIV-2) in human oral,mucosal transudate ... a point-of-care aid in the clinical diagnosis ...
    ... The OcuLight OR (532 nm) ... green product,family. The OcuLight family is ... use, and portability and it makes,up ... ophthalmic lasers. ,The OcuLight OR laser ...
    ...
    ...
    Medicine Products: